EUROPHARMEDTECH
ActiveSummary
EUROPHARMEDTECH has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-29k) and a net result of €-70k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 213 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
Checked score
Score 2025
22
/ 100
Critical
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency0▼-69
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
1.4%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.63 against 1.76 in 2024; short-term debt: 144.8% and cash: 0.4% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-52.4%
Return on assets
-127.3%
Age of the figures
9 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €-29k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
31 d late
2024
17 d early
2023
22 d late
2022
45 d early
2021
38 d early
2020
51 d early
2019
3 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-70k▼ 31.4%
2024 · €-53k
2018: €-14k
2019: €-41k
2020: €37k
2021: €3k
2022: €43k
2023: €75k
2024: €-53k
2018 → 2025
Working capital
€-30k
2024 · €37k
2018: €-11k
2019: €-47k
2020: €-5k
2021: €-40k
2022: €-20k
2023: €81k
2024: €37k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€3k-€19k▲ 465%€94k▲ 398%€41k▼ 56.4%€-29k
Operating result€6k-€57k▲ 825%€106k▲ 85.3%€-49k€-68k▼ 39.1%
Net result€3k-€43k▲ 1,420%€75k▲ 77.0%€-53k€-70k▼ 31.4%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €68k in 2025 against €49k in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €55k
Fixed assets
€5k ▼ 40.3%
Current assets
€50k ▼ 41.5%
Key figures and ratios
EBITDA
€-64k▼
2024 · €-45k
Cash flow
€-67k▼
2024 · €-50k
Solvency
-52.4%▼
2024 · 43.9%
Current ratio
0.63▼
2024 · 1.76
Debt to equity
-2.91▼
2024 · 1.28
ROA
-127.3%▼
2024 · -56.8%
Interest coverage
-30.02▼
2024 · -9.59
Debt
€84k▲
2024 · €53k
Debt ≤ 1 year
€80k▲
2024 · €48k
Income taxes
€114▼
2024 · €187
Staff costs
€58k▲
2024 · €55k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€94k€55k▼
Fixed assets21/28€9k€5k▼
Tangible fixed assets22/27€9k€5k▼
Plant, machinery and equipment23€2k€1k▼
Furniture and vehicles24€7k€4k▼
Current assets29/58€85k€50k▼
Amounts receivable within one year40/41€58k€49k▼
Trade receivables40€48k€45k▼
Other amounts receivable41€10k€4k▼
Cash at bank and in hand54/58€8k€194▼
Deferred charges and accrued income490/1€19k€930▼
Equity and liabilities
Total equity and liabilities10/49€94k€55k▼
Equity10/15€41k€-29k▼
Contributions10/11€19k€19k=
Profit (loss) carried forward14€23k€-47k▼
Amounts payable17/49€53k€84k▲
Amounts payable within one year42/48€48k€80k▲
Financial debts43€1k€668▼
Credit institutions430/8€1k€668▼
Trade debts44-€31k
Suppliers440/4-€31k
Taxes, remuneration and social security45€18k€14k▼
Taxes450/3€6k€3k▼
Remuneration and social security454/9€12k€11k▼
Other amounts payable47/48€29k€33k▲
Accrued charges and deferred income492/3€4k€4k=
Income statement
Code20242025
Non-recurring operating income76A€1k-
Remuneration, social security and pensions62€55k€58k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€3k▼
Other operating charges640/8€506€727▲
Non-recurring operating charges66A-€63
Gross operating margin9900€10k€-6k▼
Operating profit (loss)9901€-49k€-68k▼
Financial income75/76B€368€57▼
Recurring financial income75€368€57▼
Financial charges65/66B€5k€2k▼
Recurring financial charges65€5k€2k▼
Profit (loss) for the period before taxes9903€-53k€-70k▼
Income taxes67/77€187€114▼
Profit (loss) for the period9904€-53k€-70k▼
Profit (loss) for the period to be appropriated9905€-53k€-70k▼
Appropriation of the result
Profit (loss) to be appropriated9906€23k€-47k▼
Profit (loss) brought forward from the previous period14P€76k€23k▼
Social balance
Average headcount (FTE)90871.21.2=
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet €-70k
Net result drops to €-70k, the lowest in the series.
14-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
22-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 22 days late
2023
31-12
Financial
Highest result since 2018net €75k ▲77%
Operating result €106k, net result €75k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 1.95
Current ratio from 0.78 to 1.95; short-term debt falls from €91k to €85k.
16-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
23-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
10-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Back to profitnet €37k
Net result €37k after 2 loss-making years.
03-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 3 days late
2019
09-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ganshoren · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Keizer Karellaan 4001083 GanshorenGround area
605 m²
Building footprint
410 m²
Volume, LiDAR
6,299 m³
Parcel 21392A0068/00E006, Brussels · tallest building 21.9 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
EPMT
since 20172.271.315.772
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21392A0068/00E006 | Brussels | 605 m² | 1 · 410 m² | 21.9 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
BIOGRABBIT
BE 1009.728.131
Dendermonde · Eq €41,593
Docteur Stefan CONSTANTINESCU
BE 0546.822.454
Sint-Pieters-Woluwe · Eq €40,458
ImmuneWatch
BE 0774.472.942
Antwerpen · Eq €41,855
Elegent
BE 0784.411.383
Gent · Eq €42,203
Mar Jaen
BE 0736.939.583
Antwerpen · Eq €39,867
Of 761 companies in sector 72101 we hold annual accounts for 481. 227 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-11-2017
Fiscal year end31-12
Abbreviation FR
EPMT
Activities, NACEBEL 2025
72101Research and development on biotechnology
62200Computer consultancy and computer facilities management
62900Other information technology and computer services
70200Business and other management consultancy
73300Public relations and communication consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.